Green Lipids develops ionizable lipids derived from cashew nutshell liquid for use in lipid nanoparticles that enable intracellular delivery of mRNA and other nucleic acids.
Our platform integrates:
Renewable feedstock chemistry
Rational lipid design
Scalable synthesis
From raw material to final formulation, the approach is designed for efficiency, affordability, adaptability and manufacture.
Alignment with environment, social, governance (ESG) and green chemistry principles
Cost and Supply Efficiency
Lower raw material input costs
Opportunity for regional production
Reduced reliance on imported speciality ionizable lipids
Design Flexibility
Drop-in Compatibility: our ionizable lipids are designed for seamless substitution into established LNP formulations
Flexible synthesis procedures:these potentially enable formation of tunable lipid structures and optimisation for different payloads and delivery targets
Compatibility with evolving mRNA and nucleic acids platforms
Development Status
Lead lipid candidates, which function efficiently in vivo, have been identified
Ongoing optimization and validation
Accredited scale-up synthesis and manufacturing processes are in progress
Intellectual Property
Green Lipids is advancing a protected lipid platform. Patent filings in key global jurisdictions have been and are being made.
